Inanc Samil Sarici
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Inanc Samil Sarici has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
Mustafa Uygar Kalayci
Kanuni Sultan Suleyman Training and Research Hospital, Department of General Surgery, Istanbul, Turkey
4 shared publicationsOzgul Duzgun
Department of General Surgery, University of Health Sciences Umraniye Training & Research Hospital, Istanbul, Turkey
4 shared publicationsMustafa Uygar Kalaycı
Kanuni Sultan Süleyman Training and Research Hospital,Department of General Surgery, Istanbul, Turkey
3 shared publications- Shahin Ayazi
Foregut Division, Surgical Institute, Allegheny Health Network, Pittsburgh, PA, United States; Chevalier Jackson Esophageal Research Center, Western Pennsylvania Hospital, Pittsburgh, PA, United States; Department of Surgery, Drexel University, Philadelphia, PA, United States
3 shared publications Ali Koc
Department of Radiology, Kayseri Training and Research Hospital, Kayseri, Turkey
2 shared publications- Kemal Turker Ulutas
Department of Medical Biochemistry and Laboratory Medicine, Reyhanlı State Hospital, 31500 Hatay, Türkiye
2 shared publications
Latest Publications
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (7) , e01754
Endoscopic Recanalization of a Long Segment Esophageal Obstruction Using the Combined Antegrade and Retrograde Rendezvous Procedure
The combined antegrade and retrograde endoscopic rendezvous technique effectively restores patency for esophageal short-segment obstructing strictures (<3 cm). However, long-segment strictures typically require complex surgery, with endoscopic management rarely reported. We report a 44-year-old man with a 9 cm esophageal obstruction due to peptic stricture who was at high risk of esophageal resection due to severe cardiac disease and prior abdominal surgeries. He underwent successful recanalization using a rendezvous technique. Serial dilations with subsequent esophageal stenting restored luminal patency. This case highlights the feasibility of an endoscopic approach as a safe and effective alternative to surgery in long-segment peptic strictures.
- 1 July 2025
- Published by Wolters Kluwer Health in ACG Case Reports Journal
- Vol. 12 (7) , e01754
Open AccessEndoscopic Recanalization of a Long Segment Esophageal Obstruction Using the Combined Antegrade and Retrograde Rendezvous Procedure
The combined antegrade and retrograde endoscopic rendezvous technique effectively restores patency for esophageal short-segment obstructing strictures (<3 cm). However, long-segment strictures typically require complex surgery, with endoscopic management rarely reported. We report a 44-year-old man with a 9 cm esophageal obstruction due to peptic stricture who was at high risk of esophageal resection due to severe cardiac disease and prior abdominal surgeries. He underwent successful recanalization using a rendezvous technique. Serial dilations with subsequent esophageal stenting restored luminal patency. This case highlights the feasibility of an endoscopic approach as a safe and effective alternative to surgery in long-segment peptic strictures.
- Open Access
- 25 February 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (2) , 305-313
Socioeconomic Disparities in the Progression of Gastroesophageal Reflux Disease and Barrett’s Esophagus to Esophageal Adenocarcinoma
Objective: To assess the impact of socioeconomic and other factors on progression from gastroesophageal reflux disease (GERD) and Barrett's esophagus (BE) to esophageal adenocarcinoma (EAC). Background: Socioeconomic status (SES) influences outcomes in EAC, but its role in the progression from GERD and BE to EAC is not well-defined. Risk of progression may be influenced by access and engagement with endoscopic screening and surveillance, health care utilization, health literacy, and other competing social determinants of health that vary with SES. Methods: Patients diagnosed with GERD between 2015 and 2023 across a regional network of 14 hospitals and >300 clinics were reviewed for BE and EAC. U.S. Census data on wealth, income, education and occupation were used to categorize patients into low, middle, and high SES groups. Univariate and multivariable analyses were conducted to evaluate the influence of demographic, clinical, and SES factors on progression to EAC from GERD and BE. Results: Among 162,542 patients with GERD, 7604 (4.70%) developed BE and 331 (0.20%) progressed to EAC. Unemployment, disability, lack of college education, and high school non-graduation were associated with progression to EAC (all P < 0.0001). Independent predictors of disease progression included established demographic and clinical factors (all P < 0.0001), lack of private insurance (odds ratio [OR]: 1.4, P < 0.0001), and low SES (OR: 1.6, P < 0.0001). For BE to EAC progression, predictors were similar, including lack of private insurance (OR: 2.0, P = 0.015) and low SES (OR: 2.0, P = 0.028). Patients with low SES were less frequently endoscopically evaluated (4/1000 vs 10/1000, P < 0.0001) or diagnosed with BE (4/1000 vs 50/1000, P < 0.0001). They were also more likely to be diagnosed with early-onset EAC (13/1000 vs 5/1000, P = 0.0138) and metastatic EAC (77.4% vs 53.1%, P = 0.001). Among patients with BE, those with low SES had a higher rate of progression to EAC (1.77% vs 0.95%, P = 0.026). Conclusions: Low SES is associated with increased progression to EAC, with higher rates of early-onset and metastatic disease at diagnosis. Disparities in access to endoscopic screening and surveillance play a significant role, compounded by socioeconomic barriers such as limited health care engagement and competing social priorities. Integrating SES into risk stratification models alongside clinical factors is essential for improving early detection and reducing the burden of advanced disease.
- 25 February 2025
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 284 (2) , 305-313
Open AccessSocioeconomic Disparities in the Progression of Gastroesophageal Reflux Disease and Barrett’s Esophagus to Esophageal Adenocarcinoma
Objective: To assess the impact of socioeconomic and other factors on progression from gastroesophageal reflux disease (GERD) and Barrett's esophagus (BE) to esophageal adenocarcinoma (EAC). Background: Socioeconomic status (SES) influences outcomes in EAC, but its role in the progression from GERD and BE to EAC is not well-defined. Risk of progression may be influenced by access and engagement with endoscopic screening and surveillance, health care utilization, health literacy, and other competing social determinants of health that vary with SES. Methods: Patients diagnosed with GERD between 2015 and 2023 across a regional network of 14 hospitals and >300 clinics were reviewed for BE and EAC. U.S. Census data on wealth, income, education and occupation were used to categorize patients into low, middle, and high SES groups. Univariate and multivariable analyses were conducted to evaluate the influence of demographic, clinical, and SES factors on progression to EAC from GERD and BE. Results: Among 162,542 patients with GERD, 7604 (4.70%) developed BE and 331 (0.20%) progressed to EAC. Unemployment, disability, lack of college education, and high school non-graduation were associated with progression to EAC (all P < 0.0001). Independent predictors of disease progression included established demographic and clinical factors (all P < 0.0001), lack of private insurance (odds ratio [OR]: 1.4, P < 0.0001), and low SES (OR: 1.6, P < 0.0001). For BE to EAC progression, predictors were similar, including lack of private insurance (OR: 2.0, P = 0.015) and low SES (OR: 2.0, P = 0.028). Patients with low SES were less frequently endoscopically evaluated (4/1000 vs 10/1000, P < 0.0001) or diagnosed with BE (4/1000 vs 50/1000, P < 0.0001). They were also more likely to be diagnosed with early-onset EAC (13/1000 vs 5/1000, P = 0.0138) and metastatic EAC (77.4% vs 53.1%, P = 0.001). Among patients with BE, those with low SES had a higher rate of progression to EAC (1.77% vs 0.95%, P = 0.026). Conclusions: Low SES is associated with increased progression to EAC, with higher rates of early-onset and metastatic disease at diagnosis. Disparities in access to endoscopic screening and surveillance play a significant role, compounded by socioeconomic barriers such as limited health care engagement and competing social priorities. Integrating SES into risk stratification models alongside clinical factors is essential for improving early detection and reducing the burden of advanced disease.
- Open Access
- 23 February 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (3) , 454-461
Impact of Change in Sizing Protocol on Outcome of Magnetic Sphincter Augmentation
Objective: To evaluate and compare magnetic sphincter augmentation (MSA) device sizing protocols on postoperative outcomes and dysphagia. Background: Among predictors of dysphagia after MSA, device size is the only factor that may be modified. Many centers have adopted protocols to increase device size. However, there are limited data on the impact of MSA device upsizing protocols on surgical outcomes. Methods: Patients who underwent MSA were implanted with 2 or 3 beads above the sizing device’s pop-off point (POP). Clinical and objective outcomes >1 year after surgery were compared between patients implanted with POP+2-versus-POP+3 sizing protocols. Multiple subgroups were analyzed for the benefit of upsizing. Preoperative and postoperative characteristics were compared between the size patients received, regardless of protocol. Results: A total of 388 patients were implanted under POP+2 and 216 under POP+3. At a mean of 14.2 (7.9) months, pH normalization was 73.6% and 34.1% required dilation, 15.9% developed persistent dysphagia, and 4.0% required removal. The sizing protocol had no impact on persistent dysphagia (P=0.908), pH normalization (P=0.822), or need for dilation (P=0.210) or removal (P=0.191). Subgroup analysis found that upsizing reduced dysphagia in patients with 5000 (0% vs 30.4%, P=0.034). Regardless of sizing protocol, as device size increased there was a stepwise increase in the percent male sex (P30 (P3 cm (PPPPP=0.043) or removal (P=0.014). Conclusions: Upsizing from POP+2 to POP+3 does not reduce dysphagia or affect other MSA outcomes; however, patients with poor peristalsis or hypercontractile esophagus do benefit. Regardless of sizing protocol, preoperative clinical characteristics varied among device sizes, suggesting size is not a modifiable factor, but a surrogate for esophageal circumference.
- 23 February 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (3) , 454-461
Open AccessImpact of Change in Sizing Protocol on Outcome of Magnetic Sphincter Augmentation
Objective: To evaluate and compare magnetic sphincter augmentation (MSA) device sizing protocols on postoperative outcomes and dysphagia. Background: Among predictors of dysphagia after MSA, device size is the only factor that may be modified. Many centers have adopted protocols to increase device size. However, there are limited data on the impact of MSA device upsizing protocols on surgical outcomes. Methods: Patients who underwent MSA were implanted with 2 or 3 beads above the sizing device’s pop-off point (POP). Clinical and objective outcomes >1 year after surgery were compared between patients implanted with POP+2-versus-POP+3 sizing protocols. Multiple subgroups were analyzed for the benefit of upsizing. Preoperative and postoperative characteristics were compared between the size patients received, regardless of protocol. Results: A total of 388 patients were implanted under POP+2 and 216 under POP+3. At a mean of 14.2 (7.9) months, pH normalization was 73.6% and 34.1% required dilation, 15.9% developed persistent dysphagia, and 4.0% required removal. The sizing protocol had no impact on persistent dysphagia (P=0.908), pH normalization (P=0.822), or need for dilation (P=0.210) or removal (P=0.191). Subgroup analysis found that upsizing reduced dysphagia in patients with 5000 (0% vs 30.4%, P=0.034). Regardless of sizing protocol, as device size increased there was a stepwise increase in the percent male sex (P30 (P3 cm (PPPPP=0.043) or removal (P=0.014). Conclusions: Upsizing from POP+2 to POP+3 does not reduce dysphagia or affect other MSA outcomes; however, patients with poor peristalsis or hypercontractile esophagus do benefit. Regardless of sizing protocol, preoperative clinical characteristics varied among device sizes, suggesting size is not a modifiable factor, but a surrogate for esophageal circumference.
- Open Access
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Open AccessEffects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 25 March 2022
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 18 (1) , 21-24
Acute Appendicitis in Istanbul: An 8-year Retrospective Cohort Study
- 25 March 2022
- Published by Galenos Yayinevi in Medical Journal of Bakırkoy
- Vol. 18 (1) , 21-24
Acute Appendicitis in Istanbul: An 8-year Retrospective Cohort Study
- 8 September 2020
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 19 (3) , 178-183
Diagnostic Value of C-Reactive Protein/Albumin Ratio to Differentiate Simple Versus Complicated Appendicitis
- 8 September 2020
- Published by Galenos Yayinevi in Eurasian Journal of Emergency Medicine
- Vol. 19 (3) , 178-183
Diagnostic Value of C-Reactive Protein/Albumin Ratio to Differentiate Simple Versus Complicated Appendicitis
- 13 February 2019
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (5) , 359-369
Preoperative Ca125 Value Predicts Glisson Capsule Involvement in Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Aim: The difficulty of detecting lesions smaller than 1cm in the preoperative period is still a continuing problem in peritoneal carcinomatosis. Methods: The prospective data of 106peritoneal carcinomatosis patients were included this study. Preoperative AFP, carcinoembryonic antigen, CA19.9, CA125, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, mean platelet value, platelet distribution width, red cell distribution width and radiological findings compared according to Glisson capsule tumor involvement. Results: Preoperative radiological imaging methods have low accuracy in demonstrating Glisson capsule involvement. Inflammatory and serum tumor markers, except CA125, have been shown to be ineffective at detecting preoperative Glisson capsule involvement. CA125 levels higher than 52.4 were found to be significant in indicating Glisson's capsule involvement. Conclusion: CA125 is more sensitive than radiological and nuclear imaging methods in detecting tumors smaller than 1cm.
- 13 February 2019
- Published by Taylor & Francis in Biomarkers in Medicine
- Vol. 13 (5) , 359-369
Preoperative Ca125 Value Predicts Glisson Capsule Involvement in Patients with Peritoneal Carcinomatosis Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
Aim: The difficulty of detecting lesions smaller than 1cm in the preoperative period is still a continuing problem in peritoneal carcinomatosis. Methods: The prospective data of 106peritoneal carcinomatosis patients were included this study. Preoperative AFP, carcinoembryonic antigen, CA19.9, CA125, neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, mean platelet value, platelet distribution width, red cell distribution width and radiological findings compared according to Glisson capsule tumor involvement. Results: Preoperative radiological imaging methods have low accuracy in demonstrating Glisson capsule involvement. Inflammatory and serum tumor markers, except CA125, have been shown to be ineffective at detecting preoperative Glisson capsule involvement. CA125 levels higher than 52.4 were found to be significant in indicating Glisson's capsule involvement. Conclusion: CA125 is more sensitive than radiological and nuclear imaging methods in detecting tumors smaller than 1cm.
- 1 November 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (11) , 2107-2108
Is computed tomography tractography reliable in patients with anterior abdominal stab wounds?
- 1 November 2018
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 36 (11) , 2107-2108
Is computed tomography tractography reliable in patients with anterior abdominal stab wounds?
- Open Access
- 19 September 2018
- Published by IntechOpen
Laparoscopic Surgery for Gastric Cancer
In patients with gastric cancer, surgical resection is the only treatment that can offer cure or increase long-term survival. With the accumulation of experience in laparoscopic radical gastrectomy and the progress in surgical instruments, laparoscopic surgery for gastric cancer has gained popularity despite initial concerns regarding safety and oncological adequacy. As a result, laparoscopic technique has been widely applied in gastric cancer. Different meta-analyses showed that laparoscopic procedures are associated with less blood loss but longer operation time. Many studies have reported outcomes of laparoscopic surgery for early gastric cancer, but several authors also have shown that a laparoscopic approach can also be used in cases of advanced gastric cancer. We therefore conducted this study to expand our experience and to evaluate laparoscopic gastrectomy step by step in the light of recent reports while defining key points and surgical technique.
- 19 September 2018
- Published by IntechOpen
Open AccessLaparoscopic Surgery for Gastric Cancer
In patients with gastric cancer, surgical resection is the only treatment that can offer cure or increase long-term survival. With the accumulation of experience in laparoscopic radical gastrectomy and the progress in surgical instruments, laparoscopic surgery for gastric cancer has gained popularity despite initial concerns regarding safety and oncological adequacy. As a result, laparoscopic technique has been widely applied in gastric cancer. Different meta-analyses showed that laparoscopic procedures are associated with less blood loss but longer operation time. Many studies have reported outcomes of laparoscopic surgery for early gastric cancer, but several authors also have shown that a laparoscopic approach can also be used in cases of advanced gastric cancer. We therefore conducted this study to expand our experience and to evaluate laparoscopic gastrectomy step by step in the light of recent reports while defining key points and surgical technique.
- Open Access
- 5 September 2018
- Published by IntechOpen
Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Mean Platelet Volume for Detection of Resectable Pancreas Cancer
Several biomarkers have been preferred for the early diagnosis of pancreatic adenocancer (PAC), but most are not ready to be included as part of the routine diagnostic algorithm because they still lack sensitivity, specificity or reproducibility. CA19-9 is the most widely used serum-based marker for the diagnosis and follow-up of pancreatic cancer. However, CA19-9 lacks sensitivity for early or small-diameter pancreatic cancers. For more than 3 decades, information on neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), mean platelet volume (MPV) has been widely available to health care practitioners, as part of the data provided in the full blood count. However, these biomarkers have more than used in the routine. The present chapter shares the prognostic significance of the hematological parameters in the light of our own findings and recent studies in the literature.
- 5 September 2018
- Published by IntechOpen
Open AccessNeutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio, and Mean Platelet Volume for Detection of Resectable Pancreas Cancer
Several biomarkers have been preferred for the early diagnosis of pancreatic adenocancer (PAC), but most are not ready to be included as part of the routine diagnostic algorithm because they still lack sensitivity, specificity or reproducibility. CA19-9 is the most widely used serum-based marker for the diagnosis and follow-up of pancreatic cancer. However, CA19-9 lacks sensitivity for early or small-diameter pancreatic cancers. For more than 3 decades, information on neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), mean platelet volume (MPV) has been widely available to health care practitioners, as part of the data provided in the full blood count. However, these biomarkers have more than used in the routine. The present chapter shares the prognostic significance of the hematological parameters in the light of our own findings and recent studies in the literature.